EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells

Burak Kuzu, Derya Yetkin, Ceylan Hepokur iD, Oztekin Algul iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Burak Kuzu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, Van, Türkiye. Hauptthemen laut MEDLINE: Apoptosis, Benzoxazoles, Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Van YYU BAP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents the design, synthesis, and biological evaluation of a series of novel pyrrole‐tethered bisbenzoxazole (PTB) derivatives as potential apoptosis‐inducing agents targeting the MCF‐7 human breast cancer cell line. The anticancer activity of these compounds was evaluated in vitro using the MTT assay, with tamoxifen serving as the reference therapeutic agent. Compounds B8 , B14 , and B18 demonstrated remarkable cytotoxicity against MCF‐7 cells, exhibiting approximately 8‐fold lower IC 50 values compared to tamoxifen, while showing minimal effects on healthy fibroblasts. Further investigations revealed that these compounds effectively induced early‐stage apoptosis and selectively arrested the cell cycle at the G1 phase in cancer cells. Gene expression analysis confirmed selective activation of the caspase‐9‐mediated apoptotic pathway in MCF‐7 cells, providing insights into their underlying molecular mechanisms. These findings highlight the promising potential of PTB derivatives as potent anticancer agents, laying the groundwork for the development of targeted therapies for breast cancer that leverage apoptosis induction for improved therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisBenzoxazolesBreast NeoplasmsAntineoplastic AgentsPyrrolesHumansFemaleMCF-7 CellsDrug Screening Assays, AntitumorCaspase 9Structure-Activity RelationshipCell Proliferation

Stichwörter der Autor:innen

BisbenzoxazoleMTTapoptosiscell cyclecytotoxicitypyrrolesynthesis

Substanzen

BenzoxazolesAntineoplastic AgentsPyrrolesCaspase 9

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, Van, Türkiye.
  • Advance Technology Education Research and Application Centre, Mersin University, Mersin, Türkiye.
  • Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mersin University, Mersin, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, Türkiye.

ORCID-Profile: Ceylan Hepokur, Oztekin Algul

Förderung

  • Van YYU BAP

Zitieren

APA

Kuzu, B., Yetkin, D., Hepokur, C., & Algul, O. (2025). Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70078

Vancouver

Kuzu B, Yetkin D, Hepokur C, Algul O. Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70078

BibTeX
@article{Kuzu2025,
  author = {Kuzu, Burak and Yetkin, Derya and Hepokur, Ceylan and Algul, Oztekin},
  title = {Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70078}
}
Kostenlos starten →